Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV)

Seiichi Sakamoto; Hiroyuki Tanaka; Satoshi Morimoto

doi:10.3978/j.issn.2305-5839.2015.01.15

Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV)

Seiichi Sakamoto, Hiroyuki Tanaka, Satoshi Morimoto

生命薬学

研究成果: ジャーナルへの寄稿 › 編集 › 査読

7 被引用数 (Scopus)

本文言語	英語
論文番号	35
ジャーナル	Annals of Translational Medicine
巻	3
号	3
DOI	https://doi.org/10.3978/j.issn.2305-5839.2015.01.15
出版ステータス	出版済み - 3月 2015

!!!All Science Journal Classification (ASJC) codes

医学（全般）

文献へのアクセス

10.3978/j.issn.2305-5839.2015.01.15

他のファイルとリンク

引用スタイル

@article{f7180b5d893c466fa0210473427372d9,

title = "Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV)",

author = "Seiichi Sakamoto and Hiroyuki Tanaka and Satoshi Morimoto",

year = "2015",

month = mar,

doi = "10.3978/j.issn.2305-5839.2015.01.15",

language = "English",

volume = "3",

journal = "Annals of Translational Medicine",

issn = "2305-5839",

publisher = "AME Publishing Company",

number = "3",

}

TY - JOUR

T1 - Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV)

AU - Sakamoto, Seiichi

AU - Tanaka, Hiroyuki

AU - Morimoto, Satoshi

PY - 2015/3

Y1 - 2015/3

UR - http://www.scopus.com/inward/record.url?scp=85015503243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015503243&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2305-5839.2015.01.15

DO - 10.3978/j.issn.2305-5839.2015.01.15

M3 - Editorial

AN - SCOPUS:85015503243

SN - 2305-5839

VL - 3

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

IS - 3

M1 - 35

ER -